4DENT J,BRUN J,FENDRICK A M,et al.An Evidence-based Appraisal of Reflux Disease Management-the Genval Workshop Report[J].Gut,1999,44(suppl 2):1-16.
二级参考文献14
1Vaezi MF, Singh S, et al. Richter JE. Role of acid and duodenogastric reflux in esophageal mucosal injury: A review of animal and human studies. Gastroenterology, 1995,108 : 1897-1907.
2Bremner RM, Crookes PF, DeMeester TR, et al. Concentration of refluxed acid and esophageal mucosal injury. Am J Surg, 1992,164:522-527.
3Chen Jie, Xu Junying, Xu Yong, et al. Analysis on the causes for refractory GERD. Journal of Huazhong University of Science and Technology. Medical Science, 2002,22 : 47-49.
4Martinez-de-Haro L, Ortiz A, Parrilla P, et al. Intestinal metaplsia in patients with columnar lined esophagus is associated with high levels of duodenogastroesophageal reflux. Ann Surg, 2001,233 : 34-38.
5Menges M, Muller M, Zeitz M. Increased acid and bile reflux in Barrett' s esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy. Am J Gastroenterol, 2001,96 : 331-337.
6Fass R. Epidemiology and pathophysiology of symptomatic gastroesophageal reflux disease. Am J Gastroenterol, 2003, 98 (3Suppl): 2-7.
7Graham DY. The changing epidemiology of GERD: geography and helicobacter pylori. Am J Gastroenterol, 2003, 98: 1462-1470.
8Ofman JJ. The economic and quality of life impact of symptom atic gastroesophageal reflux disease. Am J Gastroenterol,2003, 98 suppl. 8-14.
9Bardhan KD. Intermittent and on- demand use of proton pump inhibitors in the management of symptomatic gastroesophageal reflux disease. Am J Gastroenterol, 2003, 98 suppl. 40-48.
10Cremonini F, Di Caro S, Delgado - Aros S, et al. Meta - analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease. Aliment Pharmacol Ther,2003, 18: 279-289.
